• About us
• Contact

Advertisement

Organisation › Details

Albumedix Ltd.

Albumedix is a science-driven, life-science company focused on enabling the creation of superior biopharmaceuticals utilizing our recombinant human albumin products. We believe in empowering excellence to enable advanced therapies and facilitate otherwise unstable drug candidates reach patients worldwide. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical and medical device companies worldwide. Headquartered in Nottingham, England with more than 100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago. *

 

	Start	1984-01-01 established
	Group	Sartorius (Group)
	Industry	Recombumin®
	Industry 2	Veltis® drug delivery technology
	Person	Møller, Jonas Skjødt (Albumedix 202007– CEO before COO since 2017)
	Person 2	Rosholm, Peter (Albumedix 201601–202006 CEO + majro shareholder before Head Novozymes Biopharma RESIGNED 7/20)
	Street	59 Castle Boulevard Castle Court
	City	NG7 1FD Nottingham
	Tel	+44-115-9553379
		Address record changed: 2024-01-05
Basic data	Employees	C: 51 to 100 (2022-08-08)
	Currency	GBP
	Annual sales	33,000,000 (revenue, expected (2022) 2022-12-31)
		* Document for »About Section«: Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer".
		Record changed: 2023-07-10

Advertisement

More documents for Sartorius (Group)

• [1] va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen....
• [2] Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen....
• [3] Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen....
• [4] Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen....
• [5] Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen....
• [6] Albumedix Ltd.. (6/1/20). "Press Release: Albumedix Announces Appointment of Gregor Kawaletz as Chief Commercial Officer"....
• [7] Albumedix Ltd.. (5/26/20). "Press Release: Albumedix Announces Jonas Skjødt Møller as New Chief Executive Officer"....
• [8] Genedata AG. (5/2/19). "Press Release: Out-of-the-Box Integration of Genedata Bioprocess with MODDE Streamlines Bioprocess Development DOE". Basel....
• [9] Sartorius AG. (4/3/17). "Press Release: Sartorius Acquires Software Company Umetrics and Closes the Acquisition of Essen BioScience". Göttingen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.